VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 60 filers reported holding VERA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,133,246 | +24.8% | 2,562,600 | +46.1% | 0.41% | +23.4% |
| Q2 2023 | $28,146,725 | +106.9% | 1,753,690 | +0.1% | 0.33% | +80.5% |
| Q1 2023 | $13,601,092 | +370.0% | 1,752,718 | +1072.0% | 0.18% | +374.4% |
| Q4 2022 | $2,893,851 | -19.8% | 149,553 | -11.7% | 0.04% | -22.0% |
| Q3 2022 | $3,607,000 | – | 169,277 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,960,231 | $40,289,000 | 12.90% |
| Kynam Capital Management, LP | 1,522,712 | $20,724,000 | 5.29% |
| Sofinnova Investments, Inc. | 3,181,442 | $43,299,000 | 3.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,825 | $281,057,000 | 2.93% |
| Octagon Capital Advisors LP | 575,000 | $7,826,000 | 2.09% |
| Vivo Capital, LLC | 666,666 | $9,073,000 | 0.91% |
| RA Capital Management | 1,578,820 | $21,488,000 | 0.57% |
| Alphabet Inc. | 301,580 | $4,105,000 | 0.22% |
| CARNEGIE MELLON UNIVERSITY | 16,060 | $219,000 | 0.11% |
| Polar Asset Management Partners Inc. | 294,300 | $4,005,000 | 0.05% |